The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First experience of LOXO-292 in the management of pediatric patients with RET-altered cancers.
 
Ulrike Gerdemann
No Relationships to Disclose
 
Young Ah Lee
No Relationships to Disclose
 
Dahlia Henry
Employment - Loxo
Stock and Other Ownership Interests - Loxo
 
Steven Smith
No Relationships to Disclose
 
Michael Vincent Ortiz
No Relationships to Disclose
 
Stephen M. Rothenberg
Employment - Loxo
Stock and Other Ownership Interests - Loxo
 
Sandya Govinda Raju
Employment - Loxo
Stock and Other Ownership Interests - Loxo
 
Michael Craig Cox
Employment - Amgen; Bayer; Loxo; Merck KGaA
Stock and Other Ownership Interests - Amgen; Bayer; Loxo; Merck KGaA
Patents, Royalties, Other Intellectual Property - US patent 62/318,041 issued to Loxo Oncology. (Inst)
 
Julia Lynne Glade Bender
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Eisai (Inst); Ignyta (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Merck; Novartis
 
Alberto S. Pappo
Consulting or Advisory Role - Loxo/Bayer; Merck; ZIOPHARM Oncology
 
A. Lindsay Frazier
Consulting or Advisory Role - Decibel Therapeutics
 
Hyoung Jin Kang
No Relationships to Disclose